KYKOY acquires ORTX @$16/ADS cash +CVR—a 97% premium to yesterday’s close (excluding the CVR): https://finance.yahoo.com/news/kyowa-kirin-acquire-orchard-therapeutics-073500807.html The nominal deal value is $387M.